Affiliation:
1. Ryazan State Medical University named after Academician I.P. Pavlov of the Ministry of Health of Russia
Abstract
Protein ABCG2 (BCRP, breast cancer resistance protein) is an efflux transmembrane protein involved in the transport of endo- and exogenous substances, as well as in the development of tumor resistance to chemotherapy. In this work, the influence of sex hormones progesterone, estradiol, and testosterone on the relative amount of ABCG2 in Caco-2 cells was studied, as well as the role of orphan receptors (farnazoid X receptor (FXR), constitutive androstane receptor (CAR), pregnane X receptor (PXR), hepatic X receptor subtype alpha (LXRa)) in this process. The amount of ABCG2 was assessed by Western blot. Hormones were used at concentrations of 1, 10, and 100 µM, exposure time was 24 h. All hormones at all concentrations caused an increase in the amount of ABCG2. Inhibition of PXR and FXR prevented the increase in ABCG2 under the action of progesterone. Suppression of CAR and PXR reduced ABCG2 levels with estradiol compared with estrogen exposure alone, but still the transporter level was higher than in controls. Inhibition of PXR and FXR reduced the effect of testosterone; however, the level of the transporter exceeded the control values. Thus, our study showed that all sex hormones at all concentrations used increased the amount of ABCG-2, that CAR and PXR are involved in the implementation of the action of estradiol, and that FXR and PXR are involved in the implementation of the effects of testosterone and progesterone.
Publisher
The Russian Academy of Sciences
Reference36 articles.
1. Doyle L.A., Yang W., Abruzzo L.V., Krogmann T., Gao Y., Rishi A.K., Ross D.D. 1998. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Nat. Acad. Sci. USA. 95 (26), 15 665–15 670. https://doi.org/10.1073/pnas.95.26.15665
2. Khunweeraphong N., Stockner T., Kuchler K. 2017. The structure of the human ABC transporter ABCG2 reveals a novel mechanism for drug extrusion. Sci. Rep. 7 (1), 13767. https://doi.org/10.1038/s41598-017-11794-w
3. Rosenberg M.F., Bikadi Z., Chan J., Liu X., Ni Z., Cai X., Ford R.C., Mao Q. 2010. The human breast cancer resistance protein (BCRP/ABCG2) shows conformational changes with mitoxantrone. Structure. 18 (4), 482–493. https://doi.org/10.1016/j.str.2010.01.017
4. Ni Z., Bikadi Z., Rosenberg M.F., Mao Q. 2010. Structure and function of the human breast cancer resistance protein (BCRP/ABCG2). Cur. Drug Metabolism. 11 (7), 603–617. https://doi.org/10.2174/138920010792927325
5. Maliepaard M., Scheffer G.L., Faneyte I.F., van Gastelen M.A., Pijnenborg A.C., Schinkel A.H., van De Vijver M.J., Scheper R.J., Schellens J.H. 2001. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res. 61 (8), 3458–3464.